Research Analysts Set Expectations for Nukkleus Q2 Earnings

Nukkleus Inc. (NASDAQ:DFNS) – Research analysts at Noble Financial boosted their Q2 2026 EPS estimates for shares of Nukkleus in a research note issued on Tuesday, July 21st. Noble Financial analyst J. Gomes now anticipates that the company will post earnings per share of ($3.11) for the quarter, up from their prior estimate of ($8.75). Noble Financial currently has a “Strong-Buy” rating on the stock. The consensus estimate for Nukkleus’ current full-year earnings is ($93.12) per share. Noble Financial also issued estimates for Nukkleus’ Q3 2026 earnings at ($2.70) EPS, Q4 2026 earnings at ($2.30) EPS, FY2026 earnings at ($4.21) EPS, FY2027 earnings at ($7.27) EPS and FY2028 earnings at ($2.18) EPS.

Nukkleus (NASDAQ:DFNS) last announced its quarterly earnings data on Wednesday, May 20th. The company reported ($142.50) earnings per share for the quarter. The company had revenue of $3.65 million for the quarter.

Other research analysts have also recently issued research reports about the stock. Wall Street Zen cut shares of Nukkleus from a “hold” rating to a “sell” rating in a research report on Saturday, April 18th. Weiss Ratings lowered shares of Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research report on Monday. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Nukkleus presently has a consensus rating of “Moderate Buy”.

Nukkleus Stock Performance

DFNS stock opened at $4.70 on Thursday. The stock’s fifty day moving average is $29.21 and its two-hundred day moving average is $146.84. The stock has a market capitalization of $3.57 million, a price-to-earnings ratio of -1.60 and a beta of -5.82. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.21 and a current ratio of 0.25. Nukkleus has a 1 year low of $4.11 and a 1 year high of $1,948.75.

Institutional Investors Weigh In On Nukkleus

A number of large investors have recently made changes to their positions in DFNS. BNP Paribas Financial Markets acquired a new stake in Nukkleus during the 2nd quarter valued at $56,000. UBS Group AG increased its stake in shares of Nukkleus by 23.3% in the third quarter. UBS Group AG now owns 80,512 shares of the company’s stock worth $564,000 after acquiring an additional 15,223 shares during the last quarter. Ausdal Financial Partners Inc. purchased a new stake in shares of Nukkleus during the third quarter worth $105,000. Geode Capital Management LLC raised its holdings in shares of Nukkleus by 193.7% during the fourth quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock worth $503,000 after acquiring an additional 82,252 shares in the last quarter. Finally, LPL Financial LLC acquired a new stake in Nukkleus during the fourth quarter valued at $120,000. Institutional investors and hedge funds own 12.47% of the company’s stock.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.